CFD:er är komplexa instrument som innebär hög risk att du förlorar pengar snabbt på grund av hävstången. 77,3% av icke-professionella investerares konton förlorar pengar när de handlar med CFD:er hos den här leverantören. Du bör överväga om du förstår hur CFD:er fungerar och om du har råd att ta den höga risken att förlora dina pengar.

Close

Affär Bayer BAYGn

Bayer realtidsdiagram

Instrumentfundament

Weekly Search
Weekly
Daily
Datum Stäng Förändring Förändring (%) Öppna Hög Låg

Senaste nyheter

Frances Wang 2025 Apr 08, 16:00

GME Stock Price: what’s the risks and challenges ahead of GME stock?

Stocks
Tommy Yap 2025 Apr 08, 16:00

Morning Note: RBNZ Rate Cut, Oil Slide, Musk's Tariff Clash

Morning Note Oil
Frances Wang 2025 Apr 07, 16:00

Stock Market Today: Dow, S&P 500 Drop, Nasdaq Rises in Volatile Session

Indices Stocks
Tommy Yap 2025 Apr 07, 16:00

Morning Note: Trade Fears Hit Nvidia, Deepen US-China Clash; UK Seeks US Deal

Morning Note USD China
Frances Wang 2025 Apr 06, 16:00

Monthly Economic Report: Insights into Growth and Trends

Fed
Tommy Yap 2025 Apr 06, 16:00

Morning Note: Markets Tumble on Tariffs, Bitcoin Below $80K & Yen Gains

Morning Note Cryptocurrencies Forex
Tommy Yap 2025 Apr 05, 16:00

Week Ahead: Will U.S. Inflation Data Surprise the Market?

Forex Indices
Tommy Yap 2025 Apr 03, 16:00

Morning Note: Oil Prices Slide, US NFP Preview, Canada Jobs Data

Morning Note Oil Forex Commodities

Info

Spread

0.13

Spread (%)

0.6684 %

Hävstångseffekt

1:5

Köp till dagslåneränta

-0.0556 %

Sälj till dagslåneränta

-0.0333 %

Valuta

EUR

Handelstider

Marknaderna är stängda

Torsdag

07:02 - 10:59

Måndag

07:02-10:59

Måndag

11:04-15:29

Tisdag

07:02-10:59

Tisdag

11:04-15:29

Onsdag

07:02-10:59

Onsdag

11:04-15:29

Fredag

07:02-10:59

Fredag

11:04-15:29

Analys och statistik

Öppna

---

Föregående stängning

---

52 veckors högsta/lägsta

--- – ---

Marknadsvärde

19741808640

Utelöpande aktier

982424000

Rapportdatum (nästa)

2018-06-06

Utd-procent

Datum efter utdelning

2025-04-28

Förväntad framtida årlig utdelningsprocent

0.11

Förväntad framtida årlig direktavkastning

0.0055

Vinst per aktie

-2.6

Läs mer om detta instrument

Bayer Bayer AG NA
Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed management as well as customer service for agriculture. This segment provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular, renal, and gynecological diseases; collaboration agreement with Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc; and collaboration and license agreement with Cytokinetics for the development and commercialization of aficamten. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Läs mer om detta instrument

Tillgång
Sälj
Köp
Förändring (%)
Relaterade instrument
Trustpilot